Description

Darsil (silymarin) Coated Tablets 22.5 mg. №30

Ingredients:

Each coated tablet contains 22.5 mg of silymarin. Other ingredients include microcrystalline cellulose, colloidal silicon dioxide, magnesium stearate, and a coating containing hypromellose, polyethylene glycol, and titanium dioxide.

Dosage:

The recommended dosage is one tablet three times a day, preferably with meals. It is important to follow the instructions provided by your healthcare provider.

Indications:

Darsil tablets are commonly used to support liver health and promote liver function. Silymarin, the active ingredient in Darsil, is known for its antioxidant and anti-inflammatory properties.

Contraindications:

Do not use Darsil tablets if you are allergic to silymarin or any other ingredients in the product. Consult your healthcare provider before starting any new medication.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Store the tablets in a cool, dry place away from direct sunlight.

Scientific Evidence:

Silymarin, the main component of Darsil tablets, has been extensively studied for its hepatoprotective effects. Research published in the journal *Phytotherapy Research* has shown that silymarin can help protect liver cells from damage and promote regeneration. Additionally, a meta-analysis published in *BioMed Research International* concluded that silymarin supplementation can significantly improve liver function tests in patients with liver diseases.

Additional Information:

It is important to note that while Darsil tablets can support liver health, they are not a substitute for a healthy diet and lifestyle. Regular exercise and a balanced diet are essential for overall well-being. If you have any concerns about your liver health, consult a healthcare professional for personalized advice.

Pharmacological Effects: Silymarin, the active ingredient in Darsil tablets, exerts its hepatoprotective effects by scavenging free radicals, inhibiting lipid peroxidation, and modulating inflammatory pathways in the liver. These actions help protect liver cells from damage and support liver function.

Clinical Trials: Clinical trials have demonstrated the efficacy of silymarin in various liver conditions, including alcoholic liver disease, non-alcoholic fatty liver disease, and viral hepatitis. A randomized controlled trial published in *Hepatology Research* showed that silymarin supplementation led to a significant reduction in liver enzymes and improved liver function in patients with non-alcoholic fatty liver disease.